awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47110069-06F00A61-0274-4246-8CC0-9C99956CA397
Q47110069-06F00A61-0274-4246-8CC0-9C99956CA397
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47110069-06F00A61-0274-4246-8CC0-9C99956CA397
Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis.
P2860
Q47110069-06F00A61-0274-4246-8CC0-9C99956CA397
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47110069-06F00A61-0274-4246-8CC0-9C99956CA397
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d988f97b1da18e6cea6062a38a7841f8988c8eb3
P2860
Idarucizumab for dabigatran overdose in a child.